MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2024 International Congress

    Use of Machine Learning for Identification of Parkinson’s Disease and Mild Cognitive Impairment through Neuroimaging and Biofluid Biomarkers: A Study from the PPMI Cohort

    A-G. Dennis, A. Strafella (Toronto, Canada)

    Objective: Since current diagnostic tests for Parkinson’s Disease (PD) and mild cognitive impairment (MCI) focus on individual biomarkers, misdiagnoses can be frequent. This research aims…
  • 2024 International Congress

    Transcranial Direct Current Stimulation and Neurofunctional Physical Therapy Improves Motor and Cognitive Symptoms in a Patient with Type 1 Spinocerebellar Ataxia – A Case Report

    C. Bedeschi, P. Junior (Barueri, Brazil)

    Objective: The aim of this research was to develop and verify the effects of a Non-Invasive Neuromodulation protocol associated with Neurofunctional Physiotherapy on motor functions,…
  • 2024 International Congress

    EEG dominant frequency as a potential biomarker of cognition in Lewy body diseases.

    R. Heo, J. Wallner, N. Mukhopadhyay, D. Krusienski, M. Barrett (Richmond, USA)

    Objective: To determine whether cognitive performance correlates with posterior dominant frequency across Lewy body diseases. Background: DLB and PDD are associated with prominent posterior slow-wave…
  • 2024 International Congress

    Spatial Memory and Processing Speed as Cornerstones in Predicting Falls in Parkinson’s Disease

    S. Anis, E. Zimmerman, E. Jansen, R. Kaya, H. Fernandez, C. Lopez-Lennon, L. Dibble, A. Rosenfeldt, J. Alberts (Cleveland, USA)

    Objective: To build a fall prediction model that includes cognitive and motor outcomes in a subset of patients with Parkinson's disease (PwPD) enrolled in the…
  • 2024 International Congress

    Cognitive Impairment in a Cohort of Patients with DBS for parkinson’s disease treatment from a multicentric Cohort in Colombia

    T. Lopez Gonzalez, S. Poveda, M. Fonseca, P. Arango, O. Rojas, G. Monsalve, J. Diez, J. Lobato, O. Bernal Pacheco (Bogota, Colombia)

    Objective: The objective of the present work is to investigate the clinical outcomes related to cognitive performance in Colombian patients with DBS treatment. Background: Parkinson's…
  • 2024 International Congress

    Neuropsychological Predictors of Cognitive Decline in Parkinson’s Disease: A Systematic Review (PDCogniCare)

    D. Pourzinal, K. Sivakumaran, J. Yang, D. Bailey, L. Mitchell, D. Brooks, A. Lehn, J. Liddle, N. Pachana, H. Tinson, K. Shrubsole, N. Dissanayaka (Herston, Australia)

    Objective: This systematic review aimed to synthesise current neuropsychological predictors of cognitive decline in Parkinson's disease (PD). Background: The observed heterogeneity of cognitive function in…
  • 2024 International Congress

    Development and Feasibility Trial of iSupport-PD, a Digital intervention for carers of people with Parkinson’s and Cognitive Impairment

    A. Hand, J. Slodkowska-Barabasz, J. Milne, A. Mccarthy, K. Greenwell (Newcastle-upon-Tyne, United Kingdom)

    Objective: Develop a digital intervention to prevent or decrease the mental and physical health problems associated with caring and improve quality of life of carers…
  • 2024 International Congress

    Neurovascular Involvement in Parkinson’s Disease Cognitive Impairment: A 4D Flow Study

    A. Deane, D. Myall, A. Pilbrow, R. Shoorangiz, A. Sharifzadeh-Kermani, T. Anderson, J. Dalrymple-Alford, C. Morgan, T. Melzer (Christchurch, New Zealand)

    Objective: To investigate the cerebrovascular contribution to cognitive decline in Parkinson’s disease (PD). Background: Cognitive impairment is a major non-motor feature of PD. Accruing evidence…
  • 2024 International Congress

    Amyloid Pathology and its association with Cognitive Status in Huntington’s Disease

    G. Olmedo Saura, J. Perez Perez, S. Martinez-Horta, A. Puig-Davi, A. Horta-Barba, A. Vazquez-Oliver, A. Campolongo, E. Rivas-Asensio, N. Salvat-Rovira, D. Alcolea, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

    Objective: To investigate the presence of beta-amyloid pathology in Huntington's disease (HD) and its potential impact on patients' cognitive status. Background: Recent evidence indicates that…
  • 2024 International Congress

    Beyond Clinical Presentation: Incorporating Neuroimaging and Biofluid Markers to Predict Progression of Parkinson’s Disease

    L. Collins-Praino, A. Mcnamara, B. Ellul, I. Baetu, S. Lau, M. Jenkinson (Adelaide, Australia)

    Objective: To assess whether including measurements of neuroimaging and biofluid-based biomarkers improves predictive ability of models of motor and non-motor progression up to 5-year follow-up…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley